We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+5.7%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$7.68B
AUM Growth
+$101M
(+1.3%)
Cap. Flow
-$193M
Cap. Flow
% of AUM
-2.51%
Top 10 Holdings %
Top 10 Hldgs %
17.01%
Holding
1,082
New
298
Increased
225
Reduced
230
Closed
304
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$123M |
| 2 |
CVS Health
CVS
|
+$75.5M |
| 3 |
VMW
VMware, Inc
VMW
|
+$62.2M |
| 4 |
Coca-Cola Europacific Partners
CCEP
|
+$51.2M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$50.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$97.3M |
| 2 |
AGN
Allergan Inc
AGN
|
+$79.1M |
| 3 |
Micron Technology
MU
|
+$67M |
| 4 |
HP
HPQ
|
+$65.4M |
| 5 |
Baxter International
BAX
|
+$55.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.38% |
| 2 | Financials | 13.7% |
| 3 | Communication Services | 11.26% |
| 4 | Technology | 9.89% |
| 5 | Industrials | 8.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HVB
701
DELISTED
HUDSON VY HLDG CORP
HVB
| $383K | 0.01% |
+15,000
| New | +$385K |
|
702
Open Text
OTEX
$5.43B
| $380K | 0.01% |
+14,358
| New | +$410K |
|
|
THS
703
DELISTED
Treehouse Foods
THS
| $366K | ﹤0.01% |
+4,309
| New | +$372K |
|
|
LNW
704
DELISTED
Light & Wonder
LNW
| $360K | ﹤0.01% |
+34,354
| New | +$433K |
|
705
W&T Offshore
WTI
$545M
| $355K | ﹤0.01% |
+69,404
| New | +$403K |
|
|
RAVN
706
DELISTED
Raven Industries Inc
RAVN
| $349K | ﹤0.01% |
+17,055
| New | +$369K |
|
707
Texas Instruments
TXN
$255B
| $343K | ﹤0.01% |
+5,986
| New | +$336K |
|
708
G-III Apparel Group
GIII
$1.47B
| $342K | ﹤0.01% |
+6,066
| New | +$312K |
|
709
Simon Property Group
SPG
$74.5B
| $341K | ﹤0.01% |
1,745
-64,824
| -97% | -$12.6M |
|
|
CRC
710
DELISTED
California Resources Corporation
CRC
| $340K | ﹤0.01% |
4,474
+3,203
| +252% | +$196K |
|
|
AUQ
711
DELISTED
AURICO GOLD INC COM
AUQ
| $340K | ﹤0.01% |
+122,800
| New | +$428K |
|
|
FLTX
712
DELISTED
Fleetmatics Group PLC
FLTX
| $334K | ﹤0.01% |
7,455
| – | – |
|
|
GOL
713
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
| $333K | ﹤0.01% |
68,615
+58,193
| +558% | +$452K |
|
714
Bloomin' Brands
BLMN
$680M
| $332K | ﹤0.01% |
+13,635
| New | +$340K |
|
715
IAMGOLD
IAG
$8.47B
| $328K | ﹤0.01% |
+175,500
| New | +$432K |
|
716
BHP
BHP
$213B
| $323K | ﹤0.01% |
+8,225
| New | +$334K |
|
717
Macy's
M
$6.15B
| $322K | ﹤0.01% |
+4,965
| New | +$320K |
|
|
QIWI
718
DELISTED
QIWI PLC
QIWI
| $322K | ﹤0.01% |
13,399
-565,272
| -98% | -$12.5M |
|
|
RDEN
719
DELISTED
ELIZABETH ARDEN INC
RDEN
| $321K | ﹤0.01% |
20,565
-20,565
| -50% | -$343K |
|
|
KLXI
720
DELISTED
KLX Inc.
KLXI
| $308K | ﹤0.01% |
+9,487
| New | +$317K |
|
|
IPXL
721
DELISTED
Impax Laboratories, Inc.
IPXL
| $294K | ﹤0.01% |
+6,270
| New | +$249K |
|
722
Xcel Energy
XEL
$51B
| $293K | ﹤0.01% |
+8,408
| New | +$301K |
|
723
Regeneron Pharmaceuticals
REGN
$68.8B
| $292K | ﹤0.01% |
+647
| New | +$274K |
|
724
Cohen & Steers
CNS
$4.18B
| $284K | ﹤0.01% |
6,939
-9,171
| -57% | -$391K |
|
725
Cognex
CGNX
$10.3B
| $283K | ﹤0.01% |
+11,408
| New | +$243K |
|
Similar funds
Marshall Wace's Q1 2015 Portfolio in Review
As of Q1 2015, Marshall Wace held 1,082 positions worth $7.68B, up 1.3% from $7.57B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace's Q1 2015 filing shows 298 new, 225 increased, 230 reduced and 304 closed positions. Its largest new stake was Viatris: 845,509 shares worth $50.2M. The largest sale was T-Mobile US, an estimated $97.3M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 18% a quarter earlier, followed by Financials and Communication Services.
- Marshall Wace's largest Q1 2015 buy was Viatris: 845,509 shares worth $50.2M.
- Marshall Wace added most to Allergan plc in Q1 2015, an estimated $123M increase.
- Marshall Wace's biggest Q1 2015 reduction was T-Mobile US, cutting an estimated $97.3M.
- Marshall Wace fully exited Allergan Inc in Q1 2015, selling an estimated $79.1M.
- Marshall Wace's ten largest holdings make up 17% of its $7.68B portfolio in Q1 2015.
- Marshall Wace opened 298 new positions and closed 304 in Q1 2015.
- Marshall Wace's portfolio value rose 1.3% quarter-over-quarter to $7.68B.
Based on Marshall Wace's 13F filing for Q1 2015, filed 11 May 2015.